US5187193A
(en)
*
|
1988-09-12 |
1993-02-16 |
University Of Rochester |
Method for stimulating transplanted bone marrow cells
|
AU6647190A
(en)
*
|
1989-10-10 |
1991-05-16 |
University Of Rochester |
Method for producing bone marrow growth cell factors
|
CA2113990A1
(en)
*
|
1991-07-26 |
1993-02-18 |
Frederick L. Moolten |
Cancer therapy utilizing malignant cells
|
US5240914A
(en)
*
|
1992-02-03 |
1993-08-31 |
Adolph Schwimmer |
Method and compositions for inhibiting tumor cell metabolism
|
US6514949B1
(en)
|
1994-07-11 |
2003-02-04 |
University Of Virginia Patent Foundation |
Method compositions for treating the inflammatory response
|
US6448235B1
(en)
|
1994-07-11 |
2002-09-10 |
University Of Virginia Patent Foundation |
Method for treating restenosis with A2A adenosine receptor agonists
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
EP0781138B1
(de)
*
|
1994-08-29 |
2008-05-21 |
Wake Forest University |
Lipid-analoge zur behandlung von viralen infektionen
|
US5807874A
(en)
*
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5767142A
(en)
*
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5616575A
(en)
*
|
1995-12-04 |
1997-04-01 |
Regents Of The University Of Minnesota |
Bioactive tricyclic ibogaine analogs
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
US5922761A
(en)
*
|
1996-09-06 |
1999-07-13 |
Medinox, Inc. |
Methods for in vivo reduction of iron levels and compositions useful therefor
|
NZ334954A
(en)
*
|
1996-09-23 |
2000-08-25 |
Univ Rutgers |
Substituted heterocycles as anti-tumor agents
|
US5916903A
(en)
*
|
1997-02-28 |
1999-06-29 |
Synapse Pahrmaceuticals International, Inc. |
Method for reducing the effects of antineoplastic disease treatment
|
US5866558A
(en)
*
|
1997-05-08 |
1999-02-02 |
Regents Of The University Of Minnesota |
6-alkynyl steroids
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
US6468519B1
(en)
|
1997-09-10 |
2002-10-22 |
Rutgers, The State University Of New Jersey |
Polyanhydrides with biologically active degradation products
|
US6140328A
(en)
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
ES2178301T3
(es)
*
|
1997-12-29 |
2002-12-16 |
Res Corp Technologies Inc |
Derivados del acido penicilanico 2-beta-sustituido-6-alquilideno como inhibidores de la beta-lactama.
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
US6051603A
(en)
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
US6025328A
(en)
*
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
US6117878A
(en)
*
|
1998-02-24 |
2000-09-12 |
University Of Virginia |
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
US6323190B1
(en)
|
1998-07-31 |
2001-11-27 |
The Univeristy Of Georgia Research Foundation, Inc. |
Estrogen mimetics lacking reproductive tract effects
|
US7427606B2
(en)
*
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
US7378400B2
(en)
*
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
US6232297B1
(en)
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
US6166003A
(en)
*
|
1999-02-17 |
2000-12-26 |
Lkt Laboratories, Inc. |
Heterocyclic compounds for cancer chemoprevention
|
WO2000048622A2
(en)
|
1999-02-22 |
2000-08-24 |
University Of Iowa Research Foundation |
Method for inhibiting inflammatory responses
|
US6080747A
(en)
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
DK1159279T3
(da)
|
1999-03-09 |
2003-02-17 |
Upjohn Co |
4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
|
US7064114B2
(en)
*
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
US6258820B1
(en)
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
AU5630800A
(en)
*
|
1999-06-22 |
2001-01-09 |
Arno F Spatola |
Antimicrobial agents
|
US6946458B2
(en)
|
1999-07-22 |
2005-09-20 |
University Of South Florida |
N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
|
US7151100B1
(en)
*
|
1999-07-23 |
2006-12-19 |
The Regents Of The University Of California |
Indole compounds useful for the treatment of cancer
|
US6903068B1
(en)
|
1999-08-17 |
2005-06-07 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
|
US7119064B2
(en)
*
|
1999-08-17 |
2006-10-10 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
|
US6852685B1
(en)
|
1999-08-17 |
2005-02-08 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
|
EP1218018A4
(de)
*
|
1999-08-17 |
2005-06-01 |
Univ Texas |
Verwendung von colostrinin, seine peptidbestandteile und ihre analogen als regulatoren bei oxidativem stress
|
MY125942A
(en)
|
1999-09-07 |
2006-09-29 |
Upjohn Co |
Aminoalkoxy carbazoles for the treatment of cns diseases
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
US7026469B2
(en)
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
US6685928B2
(en)
|
1999-12-07 |
2004-02-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions and methods
|
US20040038948A1
(en)
|
1999-12-07 |
2004-02-26 |
Uhrich Kathryn E. |
Therapeutic compositions and methods
|
CA2397835A1
(en)
*
|
2000-01-20 |
2001-07-26 |
Regents Of The University Of Minnesota |
Polypeptides with therapeutic activity and methods of use
|
EP1265896A1
(de)
|
2000-03-21 |
2002-12-18 |
PHARMACIA & UPJOHN COMPANY |
4-hydroxy-11,8-naphthyridine-3-carboxamide mit antiviraler wirkung
|
NZ521521A
(en)
|
2000-03-21 |
2004-10-29 |
Upjohn Co |
4-hydroxycinnoline-3-carboxyamides as antiviral agents
|
BR0108803A
(pt)
|
2000-03-21 |
2002-11-05 |
Upjohn Co |
4-oxo-1,4-diidro[1,8]naftiridina-3-carboxamidas como agentes antivirais
|
US6682892B2
(en)
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
US20040152672A1
(en)
*
|
2000-08-09 |
2004-08-05 |
Carson Dennis A. |
Indole compounds useful for the treatment of cancer
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
JP2004509972A
(ja)
|
2000-09-29 |
2004-04-02 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
酵母に対する殺真菌活性を有するトリテルペン
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
US6689767B2
(en)
|
2000-09-29 |
2004-02-10 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
US6958359B1
(en)
*
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
US6630462B2
(en)
|
2000-11-17 |
2003-10-07 |
Adolor Corporation |
Delta agonist analgesics
|
US20040034045A1
(en)
*
|
2000-11-29 |
2004-02-19 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
WO2002060936A2
(en)
*
|
2001-01-31 |
2002-08-08 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
US6703524B2
(en)
*
|
2001-02-20 |
2004-03-09 |
Lkt Laboratories, Inc. |
Organoselenium compounds for cancer chemoprevention
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
WO2002096826A2
(en)
*
|
2001-05-29 |
2002-12-05 |
Koninklijke Philips Electronics N.V. |
Metal-ceramic bond
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
ES2272795T3
(es)
*
|
2001-07-24 |
2007-05-01 |
Southern Methodist University Foundation For Research |
7-alquildieno-3-sustituidos-3-cefem-4-carboxilatos como inhibidores de beta-lactamasa.
|
US6753414B2
(en)
*
|
2001-08-07 |
2004-06-22 |
University Of Iowa Research Foundation, Inc. |
Process for preparing saponin compounds
|
JP2005526691A
(ja)
|
2001-08-08 |
2005-09-08 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
治療剤1H−ピリド[4,3−b]インドール
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
WO2003020728A1
(en)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
|
JP4714413B2
(ja)
*
|
2001-08-31 |
2011-06-29 |
トムソン ライセンシング |
オーディオビジュアルストリームのためのシーケンスカウンタ
|
WO2003024976A2
(en)
*
|
2001-09-21 |
2003-03-27 |
Pharmacia & Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
EP1430017A2
(de)
|
2001-09-26 |
2004-06-23 |
Theravance, Inc. |
Substituierter phenolverbindungen zur anästhesie und sedierung
|
NZ545787A
(en)
*
|
2001-10-01 |
2007-12-21 |
Univ Virginia |
2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
WO2003031587A2
(en)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Use of stat-6 inhibitors as therapeutic agents
|
AU2002350623A1
(en)
*
|
2001-10-26 |
2003-05-06 |
The Scripps Research Institute |
Targeted thrombosis by tissue factor polypeptides
|
JP4628675B2
(ja)
|
2001-11-14 |
2011-02-09 |
ラトガーズ,ザ ステイト ユニバーシティ |
可溶化トポイソメラーゼ毒
|
ATE405568T1
(de)
|
2001-11-14 |
2008-09-15 |
Univ Rutgers |
Cytotoxische mittel
|
MXPA04004701A
(es)
*
|
2001-11-23 |
2005-07-01 |
Univ Rutgers |
Sintesis mejorada de polianhidridos.
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
EP1517689A2
(de)
*
|
2002-01-25 |
2005-03-30 |
Regents Of The University Of Minnesota |
Selektive analgetika
|
CN1646140A
(zh)
*
|
2002-02-04 |
2005-07-27 |
阿尔法玛药品研发有限公司 |
可释放co的化合物在用于治疗炎症药物的制备中的应用
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
CA2475187A1
(en)
|
2002-02-07 |
2003-08-14 |
Rutgers, The State University Of New Jersey |
Therapeutic polyesters and polyamides
|
WO2003072053A2
(en)
|
2002-02-22 |
2003-09-04 |
The Curators Of The University Of Missouri |
Compounds for treatment of copper overload
|
US20050032713A1
(en)
*
|
2002-03-27 |
2005-02-10 |
Wurtman Richard J. |
Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
|
US7022691B2
(en)
*
|
2002-04-04 |
2006-04-04 |
John D. Buynak |
Inhibitors of serine and metallo-β-lactamases
|
MXPA04010560A
(es)
*
|
2002-04-25 |
2005-08-15 |
Scripps Research Inst |
Tratamiento y prevencion de condiciones pulmonares.
|
US7026472B2
(en)
*
|
2002-05-06 |
2006-04-11 |
University Of South Florida |
Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
AU2003251755A1
(en)
*
|
2002-07-05 |
2004-01-23 |
Tetragrammaton Inc. |
Methods, compositions and kits for treating damage to excitable tissue
|
AU2003265406A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted topoisomerase agents
|
JP2005538175A
(ja)
*
|
2002-09-11 |
2005-12-15 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
血液凝固過程に関与する第Xa因子および他セリンプロテアーゼのインヒビター
|
WO2004026116A2
(en)
*
|
2002-09-19 |
2004-04-01 |
The Regents Of The University Of California |
Use of etodoclac to treat hyperplasia
|
WO2004032599A2
(en)
|
2002-10-10 |
2004-04-22 |
Cornell Research Foundation, Inc. |
Novel immunogenic proteins of leptospira
|
WO2004036188A2
(en)
*
|
2002-10-18 |
2004-04-29 |
Cylene Pharmaceuticals, Inc. |
Processes for identifying quadruplex-targeted antiviral molecules
|
WO2004037851A2
(en)
*
|
2002-10-22 |
2004-05-06 |
Board Of Regents The University Of Texas System |
Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis
|
CA2509834A1
(en)
*
|
2002-10-28 |
2004-05-13 |
Paraquest, Inc. |
Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia
|
CA2505325C
(en)
|
2002-11-08 |
2014-02-25 |
Ablynx N.V. |
Stabilized single domain antibodies
|
EP1558650A2
(de)
|
2002-11-08 |
2005-08-03 |
Ablynx N.V. |
Antikörper aus camelidae gegen immunoglobulin e und ihre verwendung zur behandlung allergischer erkrankungen
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
WO2004047800A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
EP1581634A4
(de)
*
|
2002-12-10 |
2006-10-25 |
Scripps Research Inst |
Verfahren zur behandlung von drogensucht und zum screening von pharmazeutika dafür
|
US8119854B2
(en)
*
|
2002-12-10 |
2012-02-21 |
Pietro P. Sanna |
Role of proteoglycans in drug dependence
|
US7297340B2
(en)
*
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
ES2542330T3
(es)
|
2003-01-10 |
2015-08-04 |
Ablynx N.V. |
Polipéptidos terapéuticos, homólogos de los mismos, fragmentos de los mismos y su uso en modular la agregación mediada por plaquetas
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
WO2004087672A1
(en)
|
2003-03-28 |
2004-10-14 |
Cornell Research Foundation, Inc. |
Migrastatin analog compositions and uses thereof
|
AU2004229489B2
(en)
*
|
2003-04-07 |
2010-03-04 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs
|
US7163948B2
(en)
*
|
2003-04-07 |
2007-01-16 |
Cylene Pharmaceuticals, Inc. |
Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
US20040248880A1
(en)
*
|
2003-04-25 |
2004-12-09 |
Jacobsen Eric Jon |
1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
|
WO2004111192A2
(en)
*
|
2003-05-29 |
2004-12-23 |
The Scripps Research Institute |
Targeted delivery to legumain-expressing cells
|
SI1653943T1
(sl)
|
2003-06-25 |
2008-08-31 |
Burnham Inst |
Derivati katehola za zdravljenje raka
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
CN1894250B
(zh)
|
2003-08-25 |
2010-06-09 |
PGx健康有限责任公司 |
取代的8-杂芳基黄嘌呤
|
EP1660094A4
(de)
|
2003-08-26 |
2009-09-16 |
Univ Colorado |
Hemmer der serinprotease-aktivität und ihre verwendung bei verfahren und zusammensetzungen zur behandlung von bakterieninfektionen
|
WO2005020928A2
(en)
|
2003-08-29 |
2005-03-10 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
WO2005042699A2
(en)
*
|
2003-10-17 |
2005-05-12 |
Regents Of The University Of Minnesota |
Modified polypeptides with therapeutic activity and methods of use
|
DK1687338T3
(da)
|
2003-11-07 |
2011-02-07 |
Ablynx Nv |
Camelidae enkeltdomæne-antistoffer VHH, der er rettet mod epidermal vækstfaktor-receptor og anvendelser deraf
|
JP2007513180A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ザ スクリプス リサーチ インスティテュート |
喘息の処置および予防
|
EP2299266A1
(de)
*
|
2003-12-19 |
2011-03-23 |
The Regents of the University of California |
Verfahren und Materialien zur Beurteilung von Prostatakrebstherapien
|
EP1706148A2
(de)
|
2004-01-14 |
2006-10-04 |
Gilead Sciences, Inc. |
Dispersionen auf lipidbasis zur wirkstoffverabreichung
|
US7491701B2
(en)
*
|
2004-01-27 |
2009-02-17 |
Boys Town National Research Hospital |
Peptides that bind to HSP90 proteins
|
US8841326B2
(en)
|
2004-02-12 |
2014-09-23 |
Stc.Unm |
Therapeutic curcumin derivatives
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
NZ550102A
(en)
*
|
2004-02-24 |
2010-10-29 |
Univ California |
Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
|
MXPA06011219A
(es)
|
2004-03-29 |
2007-05-08 |
Univ South Florida |
Tratamiento efectivo de tumores y cancer con triciribina y compuestos relacionados.
|
WO2006001967A2
(en)
*
|
2004-05-25 |
2006-01-05 |
Sloan-Kettering Institute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
WO2006028618A1
(en)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
JP5046930B2
(ja)
*
|
2004-08-02 |
2012-10-10 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
A2aアゴニスト活性を有する修飾5’−リボース基を備えた2−プロピニルアデノシン類似体
|
US7442687B2
(en)
*
|
2004-08-02 |
2008-10-28 |
The University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having A2A agonist activity
|
WO2006026380A2
(en)
*
|
2004-08-25 |
2006-03-09 |
University Of Iowa Research Foundation |
Geranylgeranyl pyrophosphate synthase inhibitors
|
EP1796634A4
(de)
*
|
2004-09-13 |
2012-07-18 |
Gilead Sciences Inc |
Verabreichung von eisen an ein tier
|
EP1805161B1
(de)
*
|
2004-09-23 |
2014-05-07 |
Sloan-Kettering Institute For Cancer Research |
Isomigrastatinanaloga bei der krebsbehandlung
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
WO2006040153A2
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
|
US8697674B2
(en)
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
WO2006086103A2
(en)
*
|
2005-01-10 |
2006-08-17 |
University Of Virginia Patent Foundation |
Synthesis of inhibitors of p90rsk
|
US7691364B2
(en)
*
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
PL1893196T5
(pl)
|
2005-05-13 |
2015-12-31 |
Univ California |
Związek diarylohydantoinowy
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
SG184709A1
(en)
|
2005-05-18 |
2012-10-30 |
Ablynx Nv |
Improved nanobodies™ against tumor necrosis factor-alpha
|
CA2960105A1
(en)
|
2005-05-20 |
2006-11-23 |
Ablynx Nv |
Single domain vhh antibodies against von willebrand factor
|
US20070025910A1
(en)
|
2005-07-29 |
2007-02-01 |
Norenberg Jeffrey P |
Anticancer therapy
|
WO2007019308A2
(en)
*
|
2005-08-03 |
2007-02-15 |
The Regents Of The University Of California |
Illudin analogs useful as anticancer agents
|
EP1931352B1
(de)
*
|
2005-08-22 |
2016-04-13 |
The Regents of The University of California |
Tlr-agonisten
|
JP5259408B2
(ja)
|
2005-08-29 |
2013-08-07 |
ユニバーシティ オブ バージニア パテント ファンデーション |
リソフィリン類縁体とその使用方法
|
US8871764B2
(en)
|
2005-08-29 |
2014-10-28 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
EP1951260A4
(de)
|
2005-10-21 |
2009-11-11 |
Bezwada Biomedical Llc |
Funktionalisierte phenolische verbindungen und saugfähiger artikel daraus
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
WO2007064759A2
(en)
*
|
2005-11-29 |
2007-06-07 |
The Scripps Research Institute |
Inhibiting tumour cell invasion, metastasis and angiogenesis through targetting legumain
|
US8007526B2
(en)
|
2005-12-01 |
2011-08-30 |
Bezwada Biomedical, Llc |
Difunctionalized aromatic compounds and polymers therefrom
|
WO2007078615A2
(en)
*
|
2005-12-15 |
2007-07-12 |
Cavit Sciences, Inc |
Methods and compositions for treatment of cancer
|
WO2007073226A1
(en)
*
|
2005-12-20 |
2007-06-28 |
Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release co
|
US20070244057A1
(en)
*
|
2006-01-20 |
2007-10-18 |
Henry Paulson |
Suppressing polyglutamine aggregation and toxicity
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
US7615649B2
(en)
*
|
2006-01-26 |
2009-11-10 |
Iowa State University Research Foundation, Inc, |
Synthesis of polycyclic procyanidins
|
WO2007120972A2
(en)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
JP5256049B2
(ja)
*
|
2006-02-21 |
2013-08-07 |
ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション |
抗癌剤
|
AU2007217366A1
(en)
|
2006-02-27 |
2007-08-30 |
The Regents Of The University Of California |
Oxysterol compounds and the hedgehog pathway
|
NZ595571A
(en)
|
2006-02-28 |
2013-04-26 |
Helicon Therapeutics Inc |
Pyrazole compounds and uses thereof
|
CN101431996A
(zh)
*
|
2006-03-22 |
2009-05-13 |
加利福尼亚大学董事会 |
蛋白质异戊二烯基转移酶的抑制剂
|
LT3100727T
(lt)
|
2006-03-27 |
2018-12-10 |
The Regents Of The University Of California |
Androgeno receptoriaus moduliatorius, skirtas prostatos vėžio ir su androgeno receptoriumi susijusių ligų gydymui
|
WO2007127010A2
(en)
|
2006-03-29 |
2007-11-08 |
The Regents Of The University Of California |
Diarylthiohydantoin compounds
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
WO2007139778A2
(en)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Rhamnose substituents of sl0101 and therapeutic uses thereof
|
EP2700638A1
(de)
|
2006-05-31 |
2014-02-26 |
The Regents Of the University of California |
Purinanaloga
|
ES2414205T3
(es)
*
|
2006-06-02 |
2013-07-18 |
The Ohio State University Research Foundation |
Agentes terapéuticos para el tratamiento de linfoma de células del manto
|
WO2007146831A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
WO2007149277A2
(en)
|
2006-06-16 |
2007-12-27 |
Pgx Health, Llc |
Substituted 8-[6-amino-3-pyridyl]xanthines
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
EP2102144A4
(de)
|
2006-09-13 |
2011-03-23 |
Univ Rutgers |
Wirkstoffe und ihre oligomere und polymere
|
US20080206287A1
(en)
*
|
2006-09-18 |
2008-08-28 |
Reed John C |
Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands
|
US8022246B2
(en)
*
|
2006-10-10 |
2011-09-20 |
The Burnham Institute For Medical Research |
Neuroprotective compositions and methods
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
JP2010511034A
(ja)
*
|
2006-11-29 |
2010-04-08 |
ファイザー・プロダクツ・インク |
第Xa因子阻害剤としての(R)−5−メチル−4,5−ジヒドロ−ピラゾール−1,5−ジカルボン酸1−[(4−クロロ−フェニル)−アミド]5−{[2−フルオロ−4−(2−オキソ−2H−ピリジン−1−イル)−フェニル]−アミド}
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
WO2008074839A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
CA2677353C
(en)
|
2007-02-06 |
2017-04-18 |
Gerald B. Hammond |
Halogen substituted alkynes and their use in the treatment of cancer
|
CA2677733A1
(en)
|
2007-02-07 |
2008-09-25 |
The Regents Of The University Of California |
Conjugates of synthetic tlr agonists and uses therefor
|
US20100143270A1
(en)
*
|
2007-02-21 |
2010-06-10 |
University Of Louisville Research Foubdation |
Therapeutic cotinine compositions
|
JP2010520236A
(ja)
|
2007-02-28 |
2010-06-10 |
ユニバーシティ オブ バージニア パテント ファンデーション |
リソフィリンアナログとその使用法
|
US8569449B2
(en)
|
2007-05-08 |
2013-10-29 |
University Of Louisville Research Foundation, Inc. |
Synthetic peptides and peptide mimetics
|
WO2009009793A2
(en)
|
2007-07-12 |
2009-01-15 |
University Of South Florida |
Inhibitors of akt/pkb with anti-tumor activity
|
JP2010535204A
(ja)
|
2007-08-02 |
2010-11-18 |
ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー |
治療用化合物
|
WO2009025797A1
(en)
*
|
2007-08-16 |
2009-02-26 |
Burnham Institute For Medical Research |
Compositions and methods for treating symptoms of aging
|
CA2696609C
(en)
|
2007-08-27 |
2017-09-05 |
Helicon Therapeutics, Inc. |
Therapeutic isoxazole compounds
|
US8217134B2
(en)
*
|
2007-08-30 |
2012-07-10 |
Bezwada Biomedical, Llc |
Controlled release of biologically active compounds
|
US8048980B2
(en)
*
|
2007-09-17 |
2011-11-01 |
Bezwada Biomedical, Llc |
Hydrolysable linkers and cross-linkers for absorbable polymers
|
BRPI0817806A2
(pt)
*
|
2007-10-05 |
2014-10-07 |
Cylene Pharmaceuticals Inc |
Análogos de quinolona e métodos relacionados a estes
|
WO2009052443A1
(en)
|
2007-10-19 |
2009-04-23 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
EP2220050A2
(de)
|
2007-10-26 |
2010-08-25 |
The Regents Of The University Of California |
Diarylhydantoinverbindungen als androgenrezeptormodulatoren
|
WO2009059030A1
(en)
*
|
2007-10-31 |
2009-05-07 |
Burnham Institute For Medical Research |
Pyrazole derivatives as kinase inhibitors
|
EP2231164A1
(de)
|
2007-12-03 |
2010-09-29 |
The Regents of the University of California |
Oxysterole zur aktivierung von hedgehog-signalisierung, osteoinduktion, antiadipogenese und wnt-signalisierung
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
US20090202626A1
(en)
*
|
2008-02-07 |
2009-08-13 |
Carson Dennis A |
Treatment of bladder diseases with a tlr7 activator
|
WO2009108716A2
(en)
|
2008-02-27 |
2009-09-03 |
University Of Louisville Research Foundation |
Synthetic peptides
|
WO2009114539A2
(en)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
US20110046101A1
(en)
*
|
2008-03-17 |
2011-02-24 |
Dmitrienko Gary I |
Bate-lactamase inhibitors
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
EP2947097A1
(de)
|
2008-04-07 |
2015-11-25 |
Ablynx N.V. |
Gegen Notch-Signalwege gerichtete Aminosäuresequenzen und Verwendungen davon
|
NZ589036A
(en)
|
2008-05-16 |
2012-07-27 |
Ablynx Nv |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
EP2299809B1
(de)
|
2008-06-17 |
2018-10-17 |
Ben Gurion University Of The Negev R&D Authority |
Substituierte cyclohexyliden-ethyliden-octahydroinden-verbindungen
|
WO2010005534A2
(en)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
WO2010014054A1
(en)
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
RU2011108560A
(ru)
|
2008-08-05 |
2012-09-10 |
Юниверсити Оф Саут Флорида (Us) |
Способы лечения когнитивного нарушения
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
CA2733458A1
(en)
*
|
2008-08-08 |
2010-02-11 |
University Of Florida Research Foundation, Inc. |
Lipid compounds for suppression of tumorigenesis
|
US9801865B2
(en)
*
|
2008-09-24 |
2017-10-31 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
|
US8124654B2
(en)
*
|
2008-11-11 |
2012-02-28 |
Immune Modulation, Inc. |
Derivatives of hypoestoxide and related compounds
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
KR20110117705A
(ko)
|
2009-02-11 |
2011-10-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
톨-유사 수용체 조정제 및 질병의 치료
|
DK2403856T3
(da)
|
2009-03-06 |
2013-04-08 |
Univ Rutgers |
Methylendioxybenzo[i]phenanthridinderivater anvendt til behandling af cancer
|
US20100240612A1
(en)
|
2009-03-20 |
2010-09-23 |
University Of Iowa Research Foundation |
Prenylated Bisphosphonates as Anti-tuberculosis Agents
|
WO2010115998A2
(en)
|
2009-04-10 |
2010-10-14 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
MX2011010872A
(es)
|
2009-04-15 |
2012-01-19 |
Sanford Burnham Med Res Inst |
Inhibidores basados en naftaleno de proteinas anti-apoptoticas.
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
WO2010132504A1
(en)
|
2009-05-11 |
2010-11-18 |
University Of Tennessee Research Foundation |
Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
|
ES2787599T3
(es)
|
2009-05-13 |
2020-10-16 |
Univ Virginia Patent Foundation |
Inhibidores de leucemia inv(16)
|
WO2011002917A1
(en)
|
2009-06-30 |
2011-01-06 |
Pgxhealth, Llc |
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2a r agonists
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
SG177557A1
(en)
|
2009-07-09 |
2012-02-28 |
Cbt Dev Ltd |
Combined preparation for use as a medicament
|
CN102596959A
(zh)
|
2009-07-31 |
2012-07-18 |
拜奥克里斯特制药公司 |
吡咯并[1,2-b]哒嗪衍生物作为janus激酶抑制剂
|
WO2011019995A2
(en)
|
2009-08-14 |
2011-02-17 |
Hecht Sidney M |
Synthesis and identification of novel rsk-specific inhibitors
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
WO2011028638A1
(en)
|
2009-09-04 |
2011-03-10 |
Schering Corporation |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
IN2012DN02816A
(de)
*
|
2009-10-08 |
2015-07-24 |
Sanford Burnham Med Res Inst |
|
CA2780145A1
(en)
|
2009-11-05 |
2011-05-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
KR20120092175A
(ko)
|
2009-12-04 |
2012-08-20 |
죤 이. 그랜트 |
카테콜-0-메틸-트랜스퍼라제 저해제를 사용한 충동 제어 장애의 치료
|
US9096544B2
(en)
|
2009-12-23 |
2015-08-04 |
Wayne State University |
Therapeutic compounds
|
AR079705A1
(es)
|
2009-12-23 |
2012-02-15 |
Biocryst Pharm Inc |
Compuestos heterociclicos como inhibidores de janus quinasa
|
EA201792046A1
(ru)
|
2010-02-16 |
2018-05-31 |
Арагон Фармасьютикалс, Инк. |
Модуляторы рецептора андрогенов и их применение
|
EP2539348A4
(de)
|
2010-02-26 |
2013-07-24 |
Gary Igor Dmitrienko |
Cephalosporinderivate als beta-lactamase-hemmer sowie zusammensetzungen damit und verfahren zu ihrer anwendung
|
EP2552969A1
(de)
|
2010-03-29 |
2013-02-06 |
SurModics, Inc. |
Injizierbare wirkstofffreisetzungsformulierung
|
EP2552885A1
(de)
|
2010-04-02 |
2013-02-06 |
TSRL, Inc. |
Neuraminidase-inhibitoren
|
WO2011127344A2
(en)
|
2010-04-08 |
2011-10-13 |
University Of Virginia Patent Foundation |
Method to detect and treat infectious or inflammatory diarrhea
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
CA2799926A1
(en)
|
2010-05-28 |
2011-12-01 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic compounds as janus kinase inhibitors
|
CA2810162A1
(en)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
WO2011163610A2
(en)
|
2010-06-25 |
2011-12-29 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
US8741317B2
(en)
|
2010-08-19 |
2014-06-03 |
Rutgers, The State University Of New Jersey |
Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
WO2012038058A1
(en)
|
2010-09-21 |
2012-03-29 |
Telormedix Sa |
Treatment of conditions by toll-like receptor modulators
|
EP2632481A1
(de)
|
2010-10-25 |
2013-09-04 |
Regents Of The University Of Minnesota |
Therapeutische zusammensetzung zur behandlung eines glioblastoms
|
US20130216553A1
(en)
|
2010-10-29 |
2013-08-22 |
University Of Connecticut |
Compositions and Methods for Modulation and Detection of Immune and Inflammatory Responses
|
EP3363435A1
(de)
|
2010-11-01 |
2018-08-22 |
The Ohio State University Research Foundation |
Celecoxibderivate gegen staphylokokken
|
AU2011326034B2
(en)
|
2010-11-12 |
2016-02-04 |
Roche Innovation Center Copenhagen A/S |
Compositions and methods for treating androgen receptor dependent disorders including cancers
|
US8309768B2
(en)
|
2010-11-29 |
2012-11-13 |
The Ohio State University Research Foundation |
FTY720-derived anticancer agents
|
US8546397B2
(en)
|
2010-12-20 |
2013-10-01 |
The Ohio State University Research Foundation |
DNA methylation inhibitors
|
US10640464B2
(en)
|
2011-01-03 |
2020-05-05 |
The William M. Yarbrough Foundation |
Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
|
US11279674B2
(en)
|
2011-01-03 |
2022-03-22 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US11407713B2
(en)
|
2011-01-03 |
2022-08-09 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US10273205B2
(en)
|
2011-01-03 |
2019-04-30 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
|
US9962361B2
(en)
|
2011-01-03 |
2018-05-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US10308599B2
(en)
|
2011-01-03 |
2019-06-04 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US8933119B2
(en)
|
2011-01-03 |
2015-01-13 |
The William M. Yarbrough Foundation |
Method for treating phytophotodermatitis
|
US10647668B2
(en)
|
2011-01-03 |
2020-05-12 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
RS55339B1
(sr)
|
2011-02-07 |
2017-03-31 |
Biogen Ma Inc |
Agensi koji moduliraju s1p
|
US9532969B2
(en)
|
2011-02-08 |
2017-01-03 |
The William M. Yarbrough Foundation |
Method for treating psoriasis
|
AU2012225574A1
(en)
|
2011-03-07 |
2013-09-26 |
University Of Louisville Research Foundation, Inc. |
Predictive marker of DNMT1 inhibitor therapeutic efficacy and methods of using the marker
|
WO2012135697A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Novel rho kinase inhibitors and methods of use
|
US10059746B2
(en)
|
2011-04-04 |
2018-08-28 |
University Of Iowa Research Foundation |
Methods of improving vaccine immunogenicity
|
US20140030341A1
(en)
|
2011-04-06 |
2014-01-30 |
Rutgers, The State University Of New Jersey |
Polymers and methods for the treatment of pain
|
US9163044B2
(en)
|
2011-04-19 |
2015-10-20 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
US9415112B2
(en)
|
2011-06-20 |
2016-08-16 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial RNA polymerase
|
US9133230B2
(en)
|
2011-06-21 |
2015-09-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
|
EP2729483A1
(de)
|
2011-07-08 |
2014-05-14 |
Regents Of The University Of Minnesota |
Glutathionanaloga und ihre verwendung
|
EP2734235B1
(de)
|
2011-07-21 |
2017-03-22 |
Alfama, Inc. |
Kohlenmonoxidfreisetzende rutheniummoleküle und ihre verwendungen
|
EP2734519B1
(de)
|
2011-07-22 |
2016-05-04 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm verbindungen
|
KR101923250B1
(ko)
|
2011-07-29 |
2018-11-28 |
메디베이션 프로스테이트 테라퓨틱스 엘엘씨 |
유방암의 치료
|
US20150017091A1
(en)
|
2011-08-18 |
2015-01-15 |
Cornell University |
Detection and treatment of metastatic disease
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
US9034336B2
(en)
|
2011-08-30 |
2015-05-19 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
US9598441B2
(en)
|
2011-08-30 |
2017-03-21 |
Wayne State University |
Therapeutic compounds and methods
|
EP2763658B1
(de)
|
2011-09-08 |
2021-06-23 |
Western University Of Health Sciences |
Zielliposomen in der krebstherapie
|
AU2012308582B2
(en)
|
2011-09-15 |
2016-11-24 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Therapeutic compounds
|
ES2701748T3
(es)
|
2011-11-04 |
2019-02-25 |
Enceladus Pharmaceuticals B V |
Corticoesteroides liposomales para el tratamiento de trastornos inflamatorios en humanos
|
WO2013101719A2
(en)
*
|
2011-12-27 |
2013-07-04 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
US9517994B2
(en)
|
2012-01-05 |
2016-12-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
JP2015504674A
(ja)
|
2012-01-11 |
2015-02-16 |
アリゾナ ボード オブ リージェンツ ア ボディ コーポレート オブ ザ ステイト オブ アリゾナ アクティング フォー アンド オン ビハーフ オブ アリゾナ ステイト ユニバーシティーArizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
神経疾患タンパク質の二重特異性抗体フラグメントおよび使用方法
|
WO2013106756A2
(en)
|
2012-01-13 |
2013-07-18 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
US9333242B2
(en)
|
2012-01-19 |
2016-05-10 |
Hybrid Medical, Llc |
Topical therapeutic formulations
|
WO2013109972A2
(en)
|
2012-01-20 |
2013-07-25 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
US9488664B2
(en)
|
2012-01-25 |
2016-11-08 |
Sbi Pharmaceuticals Co., Ltd. |
Diagnostic agent for tumor
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
WO2013113102A1
(en)
|
2012-02-01 |
2013-08-08 |
The Governors Of The University Of Alberta |
USE OF PDGFR-α AS DIAGNOSTIC MARKER FOR PAPILLARY THYROID CANCER
|
WO2013119564A1
(en)
|
2012-02-06 |
2013-08-15 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
WO2013119946A1
(en)
|
2012-02-08 |
2013-08-15 |
Of Virginia Patent Foundation University |
Long chain base sphingosine kinase inhibitors
|
AU2013225682B2
(en)
|
2012-03-02 |
2016-04-14 |
The Board Of Trustees Of The University Of Illinois |
Potent anticancer activity via dual compound activation
|
CA2866020C
(en)
|
2012-03-06 |
2020-09-22 |
The Board Of Trustees Of The University Of Illinois |
Procaspase combination therapy for glioblastoma
|
AU2013235038A1
(en)
|
2012-03-21 |
2014-10-09 |
Malvika Kaul |
Antimicrobial agents
|
WO2013142812A1
(en)
|
2012-03-22 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechain-fluorinated myxopyronin derivatives
|
US9428493B2
(en)
|
2012-03-26 |
2016-08-30 |
University Of Iowa Research Foundation |
Schweinfurthin analogues
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
WO2013169399A1
(en)
|
2012-05-07 |
2013-11-14 |
The Regents Of The University Of California |
Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
|
EP2852390A1
(de)
|
2012-05-21 |
2015-04-01 |
Chemi Nutra Inc. |
Zusammensetzungen und verfahren zur erhöhung der festigkeit und muskelmasse
|
WO2013177458A1
(en)
|
2012-05-23 |
2013-11-28 |
Chemi Nutra |
Compositions for increasing strength, muscle mass, and lean body mass
|
EP2854834A4
(de)
|
2012-05-30 |
2016-05-18 |
Biostrategies LC |
Pflanzenlektine als träger entsprechender wirkstoffe in tierischen und menschlichen zellen
|
EP2861558B1
(de)
|
2012-06-15 |
2017-01-18 |
Rutgers, The State University of New Jersey |
Makromoleküle zur behandlung von atherosklerose
|
US9499562B2
(en)
|
2012-06-18 |
2016-11-22 |
Dart Neuroscience (Cayman) Ltd. |
Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds
|
ES2689541T3
(es)
|
2012-06-19 |
2018-11-14 |
Rutgers, The State University Of New Jersey |
Agentes antibacterianos: derivados de aril mixopironina
|
US9492448B2
(en)
|
2012-06-20 |
2016-11-15 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating glucose homeostasis and insulin action
|
CA2878413A1
(en)
|
2012-07-05 |
2014-01-09 |
University Of Iowa Research Foundation |
Therapeutic bisphosphonates
|
EP2872525B1
(de)
|
2012-07-10 |
2019-03-06 |
XPD Holdings LLC |
Stabilisierte multifunktionale antioxidative verbindungen und verfahren zur verwendung
|
WO2014015167A2
(en)
|
2012-07-18 |
2014-01-23 |
University Of Notre Dame Du Lac |
5,5-heteroaromatic anti-infective compounds
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
WO2014018874A1
(en)
|
2012-07-26 |
2014-01-30 |
The William M. Yarbrough Foundation |
Method for treating skin cancer
|
US10080734B2
(en)
|
2012-07-26 |
2018-09-25 |
The William M. Yarbrough Foundation |
Method for treating autism and other neurodevelopmental disorders
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
US9839621B2
(en)
|
2012-07-26 |
2017-12-12 |
The William M. Yarbrough Foundation |
Method for treating bladder cancer
|
US10335387B2
(en)
|
2012-07-26 |
2019-07-02 |
The William M. Yarbrough Foundation |
Method for treating infectious diseases with isothiocyanate functional compounds
|
US9949943B2
(en)
|
2012-07-26 |
2018-04-24 |
The William M. Yarbrough Foundation |
Method for treating neurodegenerative diseases
|
US10434081B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Inhibitors of macrophage migration inhibitory factor
|
US10434082B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
|
WO2014018881A1
(en)
|
2012-07-27 |
2014-01-30 |
Biogen Idec Ma Inc. |
Atx modulating agents
|
EP2879683B1
(de)
|
2012-08-01 |
2020-01-22 |
Lewis and Clark Pharmaceuticals, Inc. |
N-alkyl-alkynyladenosin-5-uronamid verbindungen als agonisten des a2a-rezeptors
|
CA2879798C
(en)
|
2012-08-03 |
2022-05-31 |
The Board Of Trustees Of The University Of Illinois |
Procaspase enzyme-activating substituted 2-(4-benzylpiperazin-1-yl)-n'-(2-hydroxybenzylidene)acetohydrazide derivatives and compostions thereof
|
US9499485B2
(en)
|
2012-08-06 |
2016-11-22 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
WO2014025708A1
(en)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Compounds that are s1p modulating agents and/or atx modulating agents
|
WO2014028025A1
(en)
|
2012-08-16 |
2014-02-20 |
University Of Southern California |
Compositions and methods for treating myotonic dystrophy type 1
|
WO2014031732A2
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
US9737493B2
(en)
|
2012-09-07 |
2017-08-22 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating DNMT1 inhibitor activity
|
US9573938B2
(en)
|
2012-09-11 |
2017-02-21 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
US9592407B2
(en)
|
2012-09-13 |
2017-03-14 |
Chang Gung Memorial Hospital |
Pharmaceutical composition and uses thereof
|
WO2014041546A1
(en)
|
2012-09-13 |
2014-03-20 |
Ben-Gurion University Of The Negev Research And Development Authority |
Diagnostic agents with enhanced sensitivity/specificity
|
NZ744456A
(en)
|
2012-09-26 |
2019-09-27 |
Aragon Pharmaceuticals Inc |
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
|
WO2014059021A1
(en)
|
2012-10-09 |
2014-04-17 |
Case Western Reserve University |
Rod-shaped plant virus nanoparticles as imaging agent platforms
|
JP2016501832A
(ja)
|
2012-10-10 |
2016-01-21 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
多機能ラジカル消光剤
|
US20140120057A1
(en)
|
2012-10-25 |
2014-05-01 |
Rutgers, The State University Of New Jersey |
Polymers and methods thereof for wound healing
|
US9296730B2
(en)
|
2012-10-26 |
2016-03-29 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
WO2014070774A1
(en)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
DK2917212T3
(da)
|
2012-11-08 |
2019-09-23 |
Univ Rutgers |
Antimikrobielle midler
|
US9701638B2
(en)
|
2012-11-09 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
AU2013344422A1
(en)
|
2012-11-16 |
2015-07-02 |
Biocryst Pharmaceuticals, Inc. |
Antiviral azasugar-containing nucleosides
|
CN105189492A
(zh)
|
2012-11-19 |
2015-12-23 |
萨克·W·金 |
麦角灵衍生物作为多巴胺受体调节剂
|
US9850206B2
(en)
|
2012-11-20 |
2017-12-26 |
Biogen Ma Inc. |
S1P and/or ATX modulating agents
|
WO2014081756A1
(en)
|
2012-11-20 |
2014-05-30 |
Biogen Idec Ma Inc. |
S1p and/or atx modulating agents
|
US9522131B2
(en)
|
2013-01-11 |
2016-12-20 |
Wisconsin Alumni Research Foundation |
Tannin-containing gastrointestinal formulations and methods of use
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
AU2014212465B2
(en)
|
2013-01-29 |
2018-07-12 |
Biogen Ma Inc. |
S1P modulating agents
|
WO2014124317A1
(en)
|
2013-02-08 |
2014-08-14 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
CN105121068A
(zh)
|
2013-02-15 |
2015-12-02 |
明尼苏达大学董事会 |
颗粒功能化
|
JP2016510749A
(ja)
|
2013-03-05 |
2016-04-11 |
ユニヴァーシティー オブ ノートル ダム デュ ラック |
キナゾリノン抗生物質
|
EP2970125B1
(de)
|
2013-03-14 |
2018-07-18 |
Dart Neuroscience (Cayman) Ltd. |
Substituierte naphthyridin- und chinolinverbindungen als mao-inhibitoren
|
CN108299400B
(zh)
|
2013-03-14 |
2021-02-19 |
达特神经科学(开曼)有限公司 |
作为pde4抑制剂的取代的吡啶和取代的吡嗪化合物
|
US9617282B2
(en)
|
2013-03-15 |
2017-04-11 |
Biogen Ma Inc. |
Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases
|
US20160039825A1
(en)
|
2013-03-15 |
2016-02-11 |
Biogen Ma Inc. |
S1p and/or atx modulating agents
|
KR20150132198A
(ko)
|
2013-03-15 |
2015-11-25 |
제넨테크, 인크. |
브로모도메인-함유 단백질 brd7 및 brd9의 억제에 의한 th2-매개 질환의 치료
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
AU2014232502B8
(en)
|
2013-03-15 |
2018-01-18 |
Rexahn Pharmaceuticals, Inc. |
Process for the preparation of 4-amino-1-((1S,4R, 5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one
|
JP2016517888A
(ja)
|
2013-05-02 |
2016-06-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
骨選択的骨形成のオキシステロール骨標的薬剤
|
ES2871116T3
(es)
|
2013-05-06 |
2021-10-28 |
Kaohsiung Chang Gung Memorial Hospital |
Composición farmacéutica de un AINE y atropina
|
US9862672B2
(en)
|
2013-05-29 |
2018-01-09 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
EP3010340A4
(de)
|
2013-06-22 |
2017-08-02 |
Nitor Therapeutics |
Zusammensetzungen und verfahren zur verstärkung einer immunantwort, zur immuntherapieverbesserung und zur erhöhung der potenz von impfstoffen
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
WO2015017715A1
(en)
|
2013-08-01 |
2015-02-05 |
Regents Of The University Of Minnesota |
Drug delivery method
|
WO2015021149A1
(en)
|
2013-08-06 |
2015-02-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ack1/tnk2 tyrosine kinase
|
CN104341504B
(zh)
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
WO2015038966A1
(en)
|
2013-09-12 |
2015-03-19 |
Regents Of The University Of Minnesota |
Semi-solid delivery systems
|
WO2015057863A1
(en)
|
2013-10-15 |
2015-04-23 |
Regents Of The University Of Minnesota |
Triorthogonal reagents for dual protein conjugation
|
WO2015070226A1
(en)
|
2013-11-11 |
2015-05-14 |
Kuality Herbceutics Llc |
Kava derived therapeutic compounds and methods of use thereof
|
US9387199B2
(en)
|
2013-11-12 |
2016-07-12 |
University Of Virginia Patent Foundation |
Compositions and methods for treating clostridium infection and preventing recurrence of infection
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
US10328040B2
(en)
|
2014-01-17 |
2019-06-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic methods
|
WO2015120320A1
(en)
|
2014-02-06 |
2015-08-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
|
WO2015123654A1
(en)
|
2014-02-17 |
2015-08-20 |
The Cleveland Clinic Foundation |
Amine passivated nanoparticles for cancer treatment and imaging
|
WO2015127125A1
(en)
|
2014-02-20 |
2015-08-27 |
Cornell University |
Compounds and methods for inhibiting fascin
|
US9908856B2
(en)
|
2014-02-26 |
2018-03-06 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
WO2015130805A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dna gridiron compositions and methods
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
EP3828173B1
(de)
|
2014-03-07 |
2022-08-31 |
BioCryst Pharmaceuticals, Inc. |
Substituierte pyrazole als menschliche plasmakallikreinhemmer
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
WO2015166355A2
(en)
|
2014-04-18 |
2015-11-05 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
SI3597649T1
(sl)
|
2014-04-23 |
2022-04-29 |
Dart Neuroscience Llc |
Sestavki, ki vsebujejo substituirane (1,2,4)triazolo(1,5-a)pirimidin-7-ilne spojine, kot zaviralci pde2
|
EP3134406A1
(de)
|
2014-04-24 |
2017-03-01 |
Dart Neuroscience (Cayman) Ltd |
Substituierte 2,4,5,6-tetrahydropyrrolo [ 3,4-c ] pyrazol-und 4,5,6,7-tetrahydro-2 h-pyrazolo [ 4,3-c ] pyridinverbindungen als glyt1-inhibitoren
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
TW201613917A
(en)
|
2014-06-06 |
2016-04-16 |
Biogen Ma Inc |
ATX modulating agents
|
US10023521B2
(en)
|
2014-06-13 |
2018-07-17 |
Rutgers, The State University Of New Jersey |
Process and intermediates for preparing poly(anhydride-esters)
|
US10138203B2
(en)
|
2014-06-16 |
2018-11-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
US20170191041A1
(en)
|
2014-07-11 |
2017-07-06 |
Biostrategies LC |
Materials and methods for treating disorders associated with sulfatase enzymes
|
WO2016011390A1
(en)
|
2014-07-18 |
2016-01-21 |
Biogen Ma Inc. |
Irak4 inhibiting agents
|
EP3265130A4
(de)
|
2014-08-19 |
2018-04-18 |
Hsiri Therapeutics, LLC |
Antibakterielle sideromycine
|
JP6629211B2
(ja)
*
|
2014-08-19 |
2020-01-15 |
国立大学法人 岡山大学 |
免疫細胞の機能増強方法及び免疫細胞の多機能性評価方法
|
US10385034B2
(en)
|
2014-09-05 |
2019-08-20 |
The Cleveland Clinic Foundation |
Flavonoid IL-17A inhibitors
|
US9630905B2
(en)
|
2014-09-08 |
2017-04-25 |
Rutgers, The State University Of New Jersey |
Amphiphilic macromolecules and methods of use thereof
|
EP3191086B1
(de)
|
2014-09-11 |
2021-05-05 |
University of Iowa Research Foundation |
Thymol und carvacol zur verwendung in der medizin
|
US10328114B2
(en)
|
2014-10-28 |
2019-06-25 |
University Of Iowa Research Foundation |
Lung injury repair compositions and methods
|
TWI601712B
(zh)
|
2014-11-05 |
2017-10-11 |
達特神經科學(開曼)有限責任公司 |
作為glyt1抑制劑之經取代之氮雜環丁基化合物
|
US10239882B2
(en)
|
2014-11-05 |
2019-03-26 |
Dart Neuroscience (Cayman) Ltd. |
Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors
|
JP2017536356A
(ja)
*
|
2014-11-10 |
2017-12-07 |
デル マー ファーマスーティカルズ |
肺の非小細胞癌及び多形性膠芽腫を処置するための放射線療法と一緒のジアンヒドロガラクチトール
|
WO2016076929A1
(en)
|
2014-11-13 |
2016-05-19 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
JP6832861B2
(ja)
|
2014-11-17 |
2021-02-24 |
セレクター・バイオサイエンシズ・インコーポレイテッド |
癌標的化薬物ビヒクルとしてのリン脂質エーテル類似体
|
US11426468B2
(en)
|
2014-12-19 |
2022-08-30 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
CN107405388A
(zh)
|
2015-01-08 |
2017-11-28 |
衣阿华大学研究基金会 |
用于体内关节软骨再生的方法
|
US10669543B2
(en)
|
2015-01-16 |
2020-06-02 |
University Of Iowa Research Foundation |
Methods to prevent or treat periodontitis or peri-implantitis
|
WO2016133959A1
(en)
|
2015-02-17 |
2016-08-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
EP3258938B1
(de)
|
2015-02-17 |
2020-12-02 |
Arizona Board of Regents on behalf of Arizona State University |
Phenothiazinanaloge als mitochondriales therapeutisches mittel
|
WO2016140978A1
(en)
|
2015-03-03 |
2016-09-09 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
WO2016140979A1
(en)
|
2015-03-03 |
2016-09-09 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
JP2018507246A
(ja)
|
2015-03-06 |
2018-03-15 |
ザ クリーヴランド クリニック ファウンデーションThe Cleveland Clinic Foundation |
ステロイド依存性疾患を治療するためのステロイド代謝の改変
|
US9926261B2
(en)
|
2015-03-10 |
2018-03-27 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
US9950993B2
(en)
|
2015-03-13 |
2018-04-24 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
JP6930918B6
(ja)
|
2015-04-10 |
2021-12-15 |
ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー |
コウジ酸ポリマー
|
WO2016179529A2
(en)
|
2015-05-06 |
2016-11-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target mc1r
|
CN108026084A
(zh)
|
2015-05-07 |
2018-05-11 |
夸利蒂赫布丘蒂克斯公司 |
治疗化合物及其使用方法
|
WO2016187100A1
(en)
|
2015-05-15 |
2016-11-24 |
The Methodist Hospital System |
Implantable nanochannel delivery devices
|
WO2016187264A1
(en)
|
2015-05-18 |
2016-11-24 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Enhanced melanoma cancer prevention by novel melanotropins
|
AU2016271527B2
(en)
|
2015-06-05 |
2021-09-02 |
The Board Of Trustees Of The University Of Illinois |
PAC-1 combination therapy
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
WO2016205397A2
(en)
|
2015-06-15 |
2016-12-22 |
Klibanov Alexander L |
Target-specific delivery of therapeutic agents
|
US10308663B2
(en)
|
2015-06-16 |
2019-06-04 |
University Of Virginia Patent Foundation |
Inhibitors of PTP4A3 for the treatment of cancer
|
US9399039B1
(en)
|
2015-06-30 |
2016-07-26 |
University Of South Florida |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
|
WO2017011686A1
(en)
|
2015-07-14 |
2017-01-19 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
US10478510B2
(en)
|
2015-07-16 |
2019-11-19 |
Case Western Resrve University |
Plant virus particles for delivery of antimitotic agents
|
EP3328372A4
(de)
|
2015-07-28 |
2019-03-20 |
University Of Iowa Research Foundation |
Zusammensetzungen und verfahren zur behandlung von krebs
|
WO2017023899A1
(en)
|
2015-08-02 |
2017-02-09 |
H. Lee Moffitt Cancer Center & Research Institute |
Inhibitors of ack1/tnk2 tyrosine kinase
|
WO2017027883A1
(en)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
CA2997430C
(en)
|
2015-09-04 |
2021-05-11 |
Janssen Pharmaceutica Nv |
Therapeutic compounds for pain and synthesis thereof
|
PT3355890T
(pt)
|
2015-10-01 |
2022-01-19 |
Biocryst Pharm Inc |
Inibidores de calicreína plasmática humana
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
EP3365018A1
(de)
|
2015-10-20 |
2018-08-29 |
The Cleveland Clinic Foundation |
Stimulierung von 11beta-hsd2-expression zur verbesserung der hormontherapie einer steroidabhängigen erkrankung
|
JP6902185B2
(ja)
|
2015-11-03 |
2021-07-14 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
Cd200阻害剤及びその使用方法
|
US10857156B2
(en)
|
2015-11-20 |
2020-12-08 |
Senhwa Biosciences, Inc. |
Combination therapy of tetracyclic quinolone analogs for treating cancer
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
ES2904557T3
(es)
|
2016-01-20 |
2022-04-05 |
Biogen Ma Inc |
Agentes inhibidores de irak4
|
TWI747873B
(zh)
|
2016-02-01 |
2021-12-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
CN109153644B
(zh)
|
2016-03-16 |
2022-10-21 |
H·李·莫菲特癌症中心研究有限公司 |
用以增强效应t细胞功能的针对cereblon的小分子
|
WO2017165558A1
(en)
|
2016-03-22 |
2017-09-28 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
EP3442979A4
(de)
|
2016-04-04 |
2019-12-18 |
Rutgers, the State University of New Jersey |
Topoisomerasegifte
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
EP4230713A1
(de)
|
2016-04-18 |
2023-08-23 |
Gene Pool Technologies, Inc. |
Isolierung von pflanzenextrakten
|
AU2017260460A1
(en)
|
2016-05-04 |
2018-12-13 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
EP3463574B1
(de)
|
2016-05-26 |
2021-11-03 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Zusammensetzungen und verfahren zur behandlung von lungengefässerkrankung
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
WO2017214296A1
(en)
|
2016-06-07 |
2017-12-14 |
University Of Iowa Research Foundation |
Junctophilin-2 fragments and uses therefor
|
US10851096B2
(en)
|
2016-06-20 |
2020-12-01 |
Rutgers, The State University Of New Jersey |
Aryl and heteroaryl amides for use as anti-proliferative, anti-thrombotic, and anti-viral agents
|
EP3474879A4
(de)
|
2016-06-24 |
2020-05-06 |
University of Iowa Research Foundation |
Zusammensetzungen und verfahren zur behandlung von melanomen
|
EP3490552B1
(de)
|
2016-07-26 |
2022-11-23 |
University of Southern California |
Selektive bromodomänenhemmung von pilz-bdf1
|
US20180037909A1
(en)
|
2016-08-04 |
2018-02-08 |
Chang Gung Memorial Hospital, Linkou |
Modified cancer cell lines and uses thereof
|
US11390605B2
(en)
|
2016-08-25 |
2022-07-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
|
WO2018044896A1
(en)
|
2016-08-31 |
2018-03-08 |
Dart Neuroscience, Llc |
Hydroxynorketamine derivatives for the treatment of cns disorders
|
MA46546A
(fr)
|
2016-10-17 |
2021-05-05 |
Genentech Inc |
Composés thérapeutiques et leurs procédés d'utilisation
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
US10759759B2
(en)
|
2016-10-31 |
2020-09-01 |
Biocryst Pharmaceuticals, Inc. |
Prodrugs of kallikrein inhibitors
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
CA3044814A1
(en)
|
2016-11-29 |
2018-06-07 |
Charles M. Brenner |
Use of nad precursors for improving maternal health and/or offspring health
|
US20180194824A1
(en)
|
2016-12-14 |
2018-07-12 |
University Of Iowa Research Foundation |
Musclin peptides and methods of use thereof
|
UY37551A
(es)
|
2016-12-27 |
2018-07-31 |
Biogen Ma Inc |
Activador de nrf2
|
KR102590848B1
(ko)
|
2016-12-28 |
2023-10-19 |
다트 뉴로사이언스, 엘엘씨 |
Pde2 억제제로서 치환된 피라졸로피리미디논 화합물
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
US11261152B2
(en)
|
2017-01-20 |
2022-03-01 |
The Regents Of The University Of California |
Inhibitors of the N-terminal domain of the androgen receptor
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
WO2018140504A1
(en)
|
2017-01-24 |
2018-08-02 |
Patel Manoj K |
Compositions and methods for blocking sodium channels
|
EP3573968A1
(de)
|
2017-01-30 |
2019-12-04 |
Biogen MA Inc. |
Nrf2-aktivator
|
WO2018140738A1
(en)
|
2017-01-30 |
2018-08-02 |
Biogen Ma Inc. |
Nrf 2 activator
|
WO2018148204A1
(en)
|
2017-02-07 |
2018-08-16 |
Biogen Ma Inc. |
Ask1 inhibiting agents
|
US11260050B2
(en)
|
2017-02-16 |
2022-03-01 |
United States Government As Represented By The Department Of Veterans Affairs |
Combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological
|
CA3061238A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Indole derivatives as efflux pump inhibitors
|
WO2018165614A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
WO2018165612A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
JOP20190233A1
(ar)
|
2017-04-14 |
2019-10-02 |
Biogen Ma Inc |
نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
CA3063174A1
(en)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
US11896591B2
(en)
|
2017-05-22 |
2024-02-13 |
University Of Virginia Patent Foundation |
Compositions and methods for preparing and using mitochondrial uncouplers
|
JP7281822B2
(ja)
|
2017-05-26 |
2023-05-26 |
ラトガーズ、ザ ステイト ユニバーシティ オブ ニュージャージー |
細菌の排出ポンプ阻害剤
|
US11603401B2
(en)
|
2017-06-02 |
2023-03-14 |
Ablynx N.V. |
Aggrecan binding immunoglobulins
|
US11261260B2
(en)
|
2017-06-02 |
2022-03-01 |
Merck Patent Gmbh |
ADAMTS binding immunoglobulins
|
MX2019014397A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Polipeptidos que enlazan adamts5, mmp13 y agrecano.
|
MX2019014448A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Inmunoglobulinas de enlace a mmp13.
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
WO2018237241A1
(en)
|
2017-06-22 |
2018-12-27 |
University Of Virginia Patent Foundation |
ATOMIC MEDICINE ACTIVATED BY PROTONS
|
EP3641776B1
(de)
|
2017-06-23 |
2023-10-18 |
San Diego State University Research Foundation |
Atropisomerismus für erhöhte kinasehemmerselektivität
|
US11458121B2
(en)
|
2017-06-26 |
2022-10-04 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds and methods to treat infection
|
MX2020000295A
(es)
|
2017-07-12 |
2020-07-22 |
Dart Neuroscience Llc |
Compuestos de benzoxazol y benzofurano sustituidos como inhibidores de pde7.
|
CN107446050A
(zh)
|
2017-08-11 |
2017-12-08 |
百奥泰生物科技(广州)有限公司 |
Trop2阳性疾病治疗的化合物及方法
|
CN111479805A
(zh)
|
2017-08-29 |
2020-07-31 |
罗格斯新泽西州立大学 |
治疗性吲唑
|
WO2019147308A2
(en)
|
2017-08-30 |
2019-08-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna nanostructures and methods of making and using rna nanostructures
|
WO2019071264A1
(en)
|
2017-10-06 |
2019-04-11 |
Blue Therapeutics, Inc. |
METHODS FOR TREATING ACUTE OR CHRONIC PAIN
|
JOP20200076A1
(ar)
|
2017-10-16 |
2020-04-30 |
Aragon Pharmaceuticals Inc |
مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال
|
WO2019079384A1
(en)
|
2017-10-17 |
2019-04-25 |
The Methodist Hospital System |
ADMINISTRATION DEVICES
|
WO2019104030A1
(en)
|
2017-11-21 |
2019-05-31 |
Biogen Ma Inc. |
Tetrahydronaphthalene derivatives useful as nrf2 activators
|
US11434247B1
(en)
|
2017-11-27 |
2022-09-06 |
Dart Neuroscience Llc |
Substituted furanopyrimidine compounds as PDE1 inhibitors
|
EP3716956A1
(de)
|
2017-11-29 |
2020-10-07 |
The Cleveland Clinic Foundation |
Antitumor-tet2-modulierende verbindungen
|
CA3083190A1
(en)
|
2017-11-30 |
2019-06-06 |
Cytogel Pharma, Llc |
Novel analgesic pharmaceutical formulations and uses thereof
|
WO2019112885A1
(en)
|
2017-12-07 |
2019-06-13 |
The Cleveland Clinic Foundation |
Treatment of steroid-resistant disease using an anthocyanin and a corticosteroid
|
US11242533B2
(en)
|
2018-01-10 |
2022-02-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA-nanostructured double robots and methods of use thereof
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
WO2019160873A1
(en)
|
2018-02-13 |
2019-08-22 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: o-alkyl-deuterated pyronins
|
RU2020130050A
(ru)
|
2018-02-15 |
2022-03-15 |
Сэньхва Байосайенсиз, Инк. |
Аналоги хинолонов и их соли, композиции и способ их применения
|
WO2019168921A1
(en)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/parp inhibitor in the treatment of cancer
|
KR20200140810A
(ko)
|
2018-02-28 |
2020-12-16 |
다트 뉴로사이언스, 엘엘씨 |
Nop 억제제로서의 치환된 사이클로헥실 화합물
|
WO2019173507A1
(en)
|
2018-03-06 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents : arylalkylcarboxamido phloroglucinols
|
US20210255170A1
(en)
|
2018-03-13 |
2021-08-19 |
University Of Iowa Research Foundation |
Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells
|
JP7453916B2
(ja)
|
2018-03-14 |
2024-03-21 |
バイオジェン・エムエイ・インコーポレイテッド |
O-糖タンパク質-2-アセトアミド-2-デオキシ-3-d-グリコピラノシダーゼ阻害剤
|
TW202010742A
(zh)
|
2018-04-06 |
2020-03-16 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
CA3097751A1
(en)
|
2018-04-20 |
2019-10-24 |
Virginia Tech Intellectual Properties, Inc. |
Oxadiazolopyrazines and oxadiazolopyridines useful as mitochondrial uncouplers
|
WO2020036654A2
(en)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
UY38233A
(es)
|
2018-05-14 |
2019-12-31 |
Biogen Ma Inc |
Agentes inhibidores para la tirosina cinasa de bruton
|
JP2021528456A
(ja)
|
2018-06-27 |
2021-10-21 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
Ask1阻害剤
|
BR112021000316A2
(pt)
|
2018-07-09 |
2021-04-06 |
Taiwan Liposome Co. Ltd |
Métodos para reduzir complicações de esteroide intra-articular
|
EA202190248A1
(ru)
|
2018-07-11 |
2021-06-16 |
Х. Ли Моффитт Кэнсер Сентер Энд Рисерч Инститьют, Инк. |
Димерные иммуномодулирующие соединения против механизмов на основе цереблона
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
US11897898B2
(en)
|
2018-08-14 |
2024-02-13 |
Biogen Ma Inc. |
Pyridine macrocycle compounds as ASK1 inhibiting agents
|
JP2021534152A
(ja)
|
2018-08-14 |
2021-12-09 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
Ask1阻害剤
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
CN113056474A
(zh)
|
2018-09-13 |
2021-06-29 |
米尼阿姆里塔治疗学有限责任公司 |
用于治疗纤维化、nash和nafld的方法中的雷公藤内酯及其前药
|
WO2020061150A1
(en)
|
2018-09-19 |
2020-03-26 |
Biogen Ma Inc. |
O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
WO2020081514A1
(en)
|
2018-10-15 |
2020-04-23 |
Biogen Ma Inc. |
Crystalline polymorphs of bruton's tyrosine kinase inhibitors
|
EP3866834A1
(de)
|
2018-10-17 |
2021-08-25 |
Sunstate Biosciences, LLC |
Einzelproteinverkapselte arzneimittel zur verstärkung therapeutischer wirkungen
|
US20210398673A1
(en)
|
2018-11-09 |
2021-12-23 |
The University Of Rochester |
Methods and systems for treating cancer based on response prediction using light scattering technology
|
MA54296A
(fr)
|
2018-11-26 |
2021-10-06 |
Denali Therapeutics Inc |
Procédés de traitement du métabolisme lipidique dérégulé
|
TW202039482A
(zh)
|
2018-12-05 |
2020-11-01 |
美商百健Ma公司 |
嗎啉基、哌嗪基、氧氮雜環庚烷基及二氮雜環庚烷基o-醣蛋白-2-乙醯胺基-2-去氧-3-d-葡萄哌喃醣苷酶抑制劑
|
JP2022517226A
(ja)
|
2019-01-14 |
2022-03-07 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
がん免疫療法のためのcd200arリガンド
|
JP2022519639A
(ja)
|
2019-02-04 |
2022-03-24 |
バイオジェン・エムエイ・インコーポレイテッド |
二環式エーテルo-糖タンパク質-2-アセトアミド-2-デオキシ-3-d-グルコピラノシダーゼ阻害剤
|
EP3935055A1
(de)
|
2019-03-08 |
2022-01-12 |
Biogen MA Inc. |
Inhibitoren der azetidinyl-0-glycoprotein-2-acetamido-2-deoxy-3-d-gluc0pyranosidase
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
MA55964A
(fr)
|
2019-05-15 |
2022-03-23 |
Biogen Ma Inc |
Agents inhibiteurs de la tyrosine kinase de bruton
|
WO2020257658A1
(en)
|
2019-06-20 |
2020-12-24 |
University Of Iowa Research Foundation |
Nanoparticles comprising quinone w methides and compositions for use
|
US20220411398A1
(en)
|
2019-06-24 |
2022-12-29 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
KR20220044276A
(ko)
|
2019-08-06 |
2022-04-07 |
바이오크리스트파마슈티컬즈,인코포레이티드 |
혈장 칼리크레인 억제제의 공정-스케일 합성
|
EP4048670A1
(de)
|
2019-10-25 |
2022-08-31 |
Accent Therapeutics, Inc. |
Mettl3-modulatoren
|
JP2023501949A
(ja)
|
2019-10-29 |
2023-01-20 |
バイオジェン・エムエイ・インコーポレイテッド |
スピロ環o-糖タンパク質-2-アセトアミド-2-デオキシ-3-d-グルコピラノシダーゼ阻害剤
|
EP4051679A1
(de)
|
2019-10-30 |
2022-09-07 |
Biogen MA Inc. |
Kondensiertes pyridazin oder pyrimidin als btk-inhibitoren
|
WO2021087112A1
(en)
|
2019-10-30 |
2021-05-06 |
Biogen Ma Inc. |
Condensed bi-heterocycles as inhibiting agents for bruton's tyrosine kinase
|
WO2021133894A1
(en)
|
2019-12-23 |
2021-07-01 |
Biogen Ma Inc. |
Btk inhibitors
|
US20230053688A1
(en)
|
2020-01-10 |
2023-02-23 |
Cornell University |
Methods to alter latency in ebv+ malignancies
|
JP2023527281A
(ja)
|
2020-05-18 |
2023-06-28 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
神経炎症の処置のためのck2阻害剤として使用するための、例えばフラボンなどのクロメン-4-オン誘導体
|
TWI813331B
(zh)
|
2020-07-10 |
2023-08-21 |
長庚醫療財團法人林口長庚紀念醫院 |
β-1腎上腺素受體拮抗劑用於製備減少表皮生長因子受體抑制劑誘導的上皮細胞損傷以及抑制癌細胞的組合物之用途
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
WO2022032019A1
(en)
|
2020-08-07 |
2022-02-10 |
Biogen Ma Inc. |
Btk inhibitors
|
WO2022051326A1
(en)
|
2020-09-02 |
2022-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lzk‑targeting degraders and methods of use
|
JP2023546549A
(ja)
|
2020-10-14 |
2023-11-02 |
アクセント・セラピューティクス・インコーポレイテッド |
Mettl3モジュレーター
|
CN117098763A
(zh)
|
2021-01-07 |
2023-11-21 |
渤健马萨诸塞州股份有限公司 |
Tyk2抑制剂
|
WO2022178437A1
(en)
|
2021-02-22 |
2022-08-25 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
TWI796023B
(zh)
|
2021-03-10 |
2023-03-11 |
長庚醫療財團法人 |
藥物組合物及其用途
|
WO2022212893A1
(en)
|
2021-04-02 |
2022-10-06 |
Biogen Ma Inc. |
Combination treatment methods of multiple sclerosis
|
WO2022235693A1
(en)
|
2021-05-04 |
2022-11-10 |
Regents Of The University Of Minnesota |
Contraceptive compounds and methods
|
EP4333899A1
(de)
|
2021-05-05 |
2024-03-13 |
Biogen MA Inc. |
Verbindungen zum targeting des abbaus der bruton-tyrosinkinase
|
WO2022271861A1
(en)
|
2021-06-22 |
2022-12-29 |
Dana-Farber Cancer Institute, Inc. |
(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl--acrylamide inhibitors of egfr for use in the treatment of brain tumors
|
WO2022271951A1
(en)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
WO2023283372A1
(en)
|
2021-07-07 |
2023-01-12 |
Biogen Ma Inc. |
Compounds for targeting degradation of irak4 proteins
|
CA3224732A1
(en)
|
2021-07-07 |
2023-01-12 |
Kevin M. Guckian |
Compounds for targeting degradation of irak4 proteins
|
AU2022340743A1
(en)
|
2021-09-01 |
2024-03-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mixed lineage kinase inhibitors and methods of use
|
WO2023081237A1
(en)
|
2021-11-03 |
2023-05-11 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
WO2023086521A1
(en)
|
2021-11-10 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
WO2023086575A1
(en)
|
2021-11-12 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
WO2023092060A1
(en)
|
2021-11-18 |
2023-05-25 |
Cornell University |
Microrna-dependent mrna switches for tissue-specific mrna-based therapies
|
WO2023130022A2
(en)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
WO2023220046A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
WO2023220049A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Crystalline polymorphs of n-methyl-n-((1s,3s)-3-methyl-3-((6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamide
|
WO2024006493A1
(en)
|
2022-07-01 |
2024-01-04 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
WO2024006977A1
(en)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
WO2024011214A1
(en)
|
2022-07-08 |
2024-01-11 |
Actio Biosciences, Inc. |
Therapeutic compounds and methods
|